Navigation Links
SeqOnce Biosciences Launches RhinoSeq™ Rapid DNA Library Preparation Kit
Date:3/23/2019

SeqOnce Biosciences Inc. launches its new RhinoSeq™ DNA Library Preparation Kit for Next Generation Sequencing (NGS) sample preparation. RhinoSeq employs a proprietary kit chemistry that makes it the fastest DNA library preparation kit for the NGS market. The five-tube kit is comprised of preformatted master mixes for a simple, fast, and stable workflow. The 12-minute library construction uses a single master-mix that when combined with fragmentation and PCR steps produces libraries in less than 45 minutes. A single size selection step occurs after PCR and the PCR free protocol is less than 20 minutes. Best results are achieved with DNA input between 5ng - 100ng.

“Our RhinoSeq DNA Library Preparation Kit is a major advancement relative to all other library preparation kits on the market, and is the first of several product launches that SeqOnce is preparing,” said Chris Angermayer, CEO of SeqOnce. “A hallmark of all our products is a fast and simple workflow based upon our revolutionary technologies, reducing a costly and often challenging step in the NGS workflow. The first version of RhinoSeq supports all the Illumina® platforms and we are working with several other NGS platform providers to expand the product’s market.”

Dr. Joseph Dunham, Chief Science Officer of SeqOnce and developer of the technology stated, “We are excited about the release of the new RhinoSeq DNA Library Preparation Kit. The new technology is applied to fragmented DNA from any sample source and any genome. It generates a temporary structure that creates sequence specific single stranded overhangs for the fast and efficient ligation of sequencing adaptors. The temporary structure is degraded throughout the protocol steps, and is not sequenced.”

This is the first product launch for SeqOnce, and it supports all genomic based DNA library needs for the Illumina platforms across a spectrum of different applications.

About SeqOnce Biosciences, Inc.  
SeqOnce Biosciences is developing innovative technologies and products for NGS that addresses critical research and clinical needs facing today’s scientists. Learn more at http://www.seqonce.com

Read the full story at https://www.prweb.com/releases/seqonce_biosciences_launches_rhinoseq_rapid_dna_library_preparation_kit/prweb16186681.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. StressMarq Biosciences Inc. PCT Patent Application for a Novel Antibody Therapeutic Candidate to Combat Parkinson’s Disease is Published
2. Fluxion Biosciences Receives National Cancer Institute Grant for Development of ERASE-Seq Liquid Biopsy Technology
3. ACEA Biosciences Joins Cell Manufacturing Research Initiative to Further Advance Cell Therapy Discovery
4. Tosoh Bioscience LLC invests in Semba Biosciences
5. ACEA Biosciences Launches xCELLigence® RTCA Software Pro to Further Enhance Immuno-Oncology Experimental Design and Analysis
6. ACEA Biosciences Releases New Version of NovoExpress® Flow Cytometry Software.
7. ACEA Biosciences Introduces an Exploratory xCELLigence® RTCA S16 Instrument
8. Pressure BioSciences Closes Additional $745,000 of $5 Million PIPE; Funding Received to Date Exceeds $4,000,000
9. The new Africa -- green shoots in biosciences
10. Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies
11. Wellspring Biosciences Founder Publishes In Nature On Discovery of Small Molecule Inhibitors of K-Ras
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2020)... (PRWEB) , ... February 06, ... ... clinical research organization (CRO) specializing in complex interventional medical device and pharmaceutical ... President, Regulatory Strategy. In this newly established role, Dorothy oversees the development ...
(Date:2/1/2020)... ... February 01, 2020 , ... Liver cancer, called hepatocellular carcinoma (HCC), occurs ... from the disease. HCC is the 5th most common cancer and the 2nd leading ... it comes to incidence of HCC, while China has half of all patients suffering ...
(Date:1/29/2020)... ... January 29, 2020 , ... VGXI, a world leading ... a DNA vaccine against the novel coronavirus (2019-nCoV) that has recently emerged in ... to $9 million from the Coalition for Epidemic Preparedness Innovations (CEPI) will fund ...
Breaking Biology News(10 mins):
(Date:2/3/2020)... (PRWEB) , ... February 03, 2020 , ... ... Travel, Financial Services Firm Travel, Law Firm Travel, Technology Industry Travel and Biotech/Healthcare ... findings, listed quarterly. Each Index illustrates the following statistics:, ...
(Date:1/28/2020)... , ... January 28, 2020 ... ... enterprise software solutions for biopharmaceutical R&D, today announced the release of ... Genedata’s focus on supporting the implementation of Multi-Attribute Methods (MAM) for characterizing ...
(Date:1/27/2020)... ... January 27, 2020 , ... Valencell, the ... from strategic investors led by Halma plc , a FTSE 100 global ... Ventures, GII LLC, and WSJ Joshua Fund. A representative from Halma will join ...
(Date:1/24/2020)... ... January 24, 2020 , ... Sierra Instruments, global ... meters and controllers ideal for BioPharm OEMS. Sierra also announces ... These thermal instruments employ high-precision MEMS (Micro-Electro Mechanical Systems) technology utilizing an advanced, ...
Breaking Biology Technology: